Liver transplantation for XXXX .

@entity1 @entity82 @entity697 @entity3182 @entity1956 @entity879 @entity281 @entity3851 @entity1576
PURPOSE: To evaluate the outcome of liver transplantation for @entity879 . @entity1 AND METHODS: From November 1991 to December 2007, 517 @entity1 underwent liver transplantation at Queen Mary Hospital, Hong Kong. Among them, 149 had @entity879 as defined in the recent Asian Pacific Association for the Study of Liver Consensus Meeting. Their clinical data were reviewed and their survival outcomes were compared with those of @entity1 who underwent liver transplantation for @entity879 and for @entity82 only in the same period. RESULTS: The @entity1 with @entity879 included 50 @entity1 having acute exacerbation of chronic @entity1956 and 99 cirrhotic @entity1 with @entity697 . Their median model for @entity3851 scores were 35 and 37, respectively. @entity281 (35%), @entity3182 (38%), and @entity1576 (28.8%) were common. One hundred and three @entity1 received living donor liver grafts and 46 @entity1 received deceased donor liver grafts. The hospital mortality rate was 4.7%. The 5-year survival rates were 93.2% for @entity1 with acute exacerbation of chronic @entity1956 and 90.5% for cirrhotic @entity1 with @entity697 . The results were similar to those of the @entity1 with @entity879 (n = 37) and the @entity1 having @entity82 only (n = 301). CONCLUSIONS: Liver transplantation for @entity879 is life-saving, and the survival rates it attains are similar to those attained by transplantation for other liver conditions.
